FAM183B Inhibitors
FAM183B Inhibitors encompass a variety of chemical compounds that hinder the functional activity of FAM183B by manipulating distinct cellular pathways. Cyclosporin A, through its inhibition of calcineurin, curtails NFAT signaling, which may result in the downregulation of FAM183B if its expression is guided by NFAT. Similarly, W-7 can impede calmodulin-dependent kinases, potentially obstructing any FAM183B regulation by these kinases. Rapamycin's action as an mTOR inhibitor attenuates protein synthesis, which would diminish FAM183B activity if it is under mTOR regulation. On the other hand, LY 294002 and PD 98059 act as inhibitors for PI3K and MEK, respectively, potentially curtailing FAM183B activity by disrupting the PI3K/AKT and MAPK/ERK pathways, which may control FAM183B expression or activation. Additionally, SB 203580's inhibition of p38 MAPK could suppress FAM183B activity involved in stress responses, while Brefeldin A could limit the functional activity of FAM183B by inhibiting its transport from the ER to the Golgi apparatus.
Further contributing to the inhibition portfolio are Thapsigargin and U-73122, which through the perturbation of calcium homeostasis and inhibition of phospholipase C, respectively, could lead to a decrease in FAM183B activity if it is calcium-dependent. Chelerythrine Chloride and Gö 6976, as PKC inhibitors, have the potential to diminish FAM183B function if PKC-mediated phosphorylation is crucial for its activity. The JNK inhibitor SP600125 could also play a role in inhibiting FAM183B if it is part of JNK-associated signaling pathways. These inhibitors collectively exert their influence by disrupting the specific biochemical pathways that FAM183B is involved in, leading to its functional inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin. By inhibiting calcineurin, Cyclosporin A reduces the activity of NFAT (nuclear factor of activated T-cells) signaling, which could decrease the expression of FAM183B if FAM183B expression is NFAT-responsive. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that interferes with calcium-calmodulin dependent processes. If FAM183B activity is regulated by calmodulin-dependent kinases, W-7 could diminish FAM183B activity by inhibiting these kinases. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that leads to reduced protein synthesis and cell proliferation. If FAM183B is involved in pathways that are positively regulated by mTOR, its inhibition would lead to a decrease in FAM183B activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that would downregulate AKT signaling, potentially diminishing the activity of proteins like FAM183B if they are downstream of PI3K/AKT pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that blocks the MAPK/ERK pathway. If the expression or activity of FAM183B is mediated by the MAPK/ERK signaling, PD 98059 could reduce FAM183B activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor which could decrease the activity of FAM183B if it is involved in stress or inflammatory responses mediated by p38 MAPK. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of ADP-ribosylation factor (ARF), which disrupts protein transport from the endoplasmic reticulum to the Golgi apparatus. If FAM183B requires Golgi-mediated processing or trafficking, Brefeldin A could inhibit its functional activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor, leading to increased cytosolic calcium levels. If FAM183B activity is calcium-sensitive and regulated by calcium homeostasis, Thapsigargin could inhibit its function. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
A PKC inhibitor that could diminish FAM183B activity if FAM183B function is modulated by PKC-mediated phosphorylation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which might decrease FAM183B activity if it plays a role in JNK-related stress or apoptosis signaling pathways. | ||||||